Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
CRL Charles River
- 183.160
- -6.170-3.26%
Close Dec 18 16:00 ET
- 183.520
- +0.360+0.20%
Pre 07:39 ET
9.37BMarket Cap22.87P/E (TTM)
191.610High182.920Low670.80KVolume190.260Open189.330Pre Close124.84MTurnover1.33%Turnover Ratio19.87P/E (Static)51.14MShares275.00052wk High2.48P/B9.26BFloat Cap176.48052wk Low--Dividend TTM50.58MShs Float460.210Historical High--Div YieldTTM4.59%Amplitude17.188Historical Low186.107Avg Price1Lot Size
About Charles River Company
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Company Profile
SymbolCRL
Company NameCharles River
Listing DateJun 23, 2000
Issue Price16.00
Founded1947
CEOMr. James C. Foster
MarketNYSE
Employees21800
Fiscal Year Ends12-28
Address251 Ballardvale Street
CityWilmington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01887
Phone1-781-222-6000
Websitehttp://www.criver.com
Company Executives
- Name
- Position
- Salary
- James C. Foster
- Chairman of the Board, President and Chief Executive Officer
- 14.10M
- Flavia H. Pease
- Corporate Executive Vice President and Chief Financial Officer
- 3.81M
- Michael Gunnar Knell
- Corporate Senior Vice President and Chief Accounting Officer
- --
- Birgit Girshick
- Chief Operating Officer
- 4.99M
- William D. Barbo
- Corporate Executive Vice President and Chief Commercial Officer
- 2.91M
- Joseph W. LaPlume
- Corporate Executive Vice President, Corporate Development and Strategy
- 3.06M
- Victoria L. Creamer
- Corporate Executive Vice President
- --
- Shannon M. Parisotto
- Corporate Executive Vice President
- --
- Reshema Kemps-Polanco
- Director
- --
- Dr. Nancy C. Andrews, M.D.,PhD
- Independent Director
- 339.77K
- George Llado, Sr
- Independent Director
- 324.77K
- Dr. Martin W. Mackay, PhD
- Independent Director
- 336.02K
- Richard F. Wallman
- Independent Director
- 339.77K
- Dr. Deborah T. Kochevar
- Independent Director
- 339.77K
- George E. Massaro
- Lead Independent Director
- 371.02K
- Robert J. Bertolini
- Independent Director
- 346.02K
- Virginia M. Wilson
- Independent Director
- 346.02K
- Dr. Craig B. Thompson,M.D.
- Independent Director
- 437.78K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
